Lupus News and Research

Latest Lupus News and Research

Rigel reports net loss of $21.5 million for second quarter 2011

Rigel Pharmaceuticals, Inc. today reported financial results for the second quarter and six months ended June 30, 2011.

2 Aug 2011

Anthera reports increase in second quarter total operating expenses to $22.7 million

Anthera Pharmaceuticals, Inc., today announced financial results and business highlights for the quarter ended June 30, 2011.

29 Jul 2011

AARDA develops a plan to calculate one's own Autoimmune Quotient

Hollywood bombshell Kim Kardashian recently shared her diagnosis of the autoimmune disease psoriasis on her E! reality TV series, "Keeping Up With The Kardashians."

29 Jul 2011

RegeneRx to initiate enrollment in RGN-259 Phase 2 trial for dry eye syndrome

RegeneRx Biopharmaceuticals, Inc. has announced that it is set to begin a Phase 2 clinical trial in 72 patients with dry eye syndrome.

29 Jul 2011

Janssen receives FDA Complete Response letter for SIMPONI sBLA to treat RA

Janssen Biotech, Inc. announced today that the U.S. Food and Drug Administration (FDA) issued a Complete Response letter for its supplemental Biologics License Application (sBLA) for SIMPONI.

25 Jul 2011

GIDAC recommends FDA approval of Janssen's REMICADE for treatment of pediatric UC

Janssen Biotech, Inc., formerly Centocor Ortho Biotech Inc., announced today that the Gastrointestinal Drugs Advisory Committee of the U.S. Food and Drug Administration recommended the approval of REMICADE for the treatment of moderately to severely active ulcerative colitis in pediatric patients who have had an inadequate response to conventional therapy.

22 Jul 2011

U.S. News & World Report ranks HSS as No.1 orthopedic hospital

U.S. News & World Report has once again named Hospital for Special Surgery (HSS) the top hospital in the country for orthopedics in its 2011 "America's Best Hospitals" issue.

19 Jul 2011

Scientists identify key immune system regulator in white blood cells

St. Jude Children's Research Hospital scientists provide insight into immune system biology and identify the mechanism that keeps white blood cell activity at a minimum until the specific immune response is needed.

18 Jul 2011

EC grants marketing authorization for BENLYSTA to treat SLE

GlaxoSmithKline and Human Genome Sciences, Inc. announced today that the European Commission has granted marketing authorization for BENLYSTA 10mg/kg as an add-on therapy in adult patients with active autoantibody-positive systemic lupus erythematosus, with a high degree of disease activity, despite standard therapy.

14 Jul 2011

Study reports high prevalence of vitamin D insufficiency in patients with psoriatic arthritis

New research reports a high prevalence of vitamin D insufficiency and deficiency among patients with psoriatic arthritis. Seasonal variation in vitamin D levels was not observed in patients in southern or northern locations.

11 Jul 2011

Transplants with half-matched bone marrow or cord blood are comparable to fully matched tissue

Identifying a suitable donor for leukemia and lymphoma patients who need bone marrow transplants may be far easier now that results of two clinical trials show transplant results with half-matched bone marrow or umbilical cord blood are comparable to fully matched tissue, thanks in large part to the availability of effective antirejection drugs and special post-transplant chemotherapy.

8 Jul 2011

Half-matched transplants widen donor pool for leukemia and lymphoma

7 Jul 2011

Zalicus commences Synavive SYNERGY Phase 2b clinical trial for rheumatoid arthritis

Zalicus Inc. a biopharmaceutical company that discovers and develops novel treatments for patients suffering from pain and immuno-inflammatory diseases today announced the initiation of the SYNERGY trial, a Phase 2b clinical trial evaluating Synavive, a low-dose glucocorticoid with the potential for amplified immuno-inflammatory benefits, in patients with rheumatoid arthritis (RA).

29 Jun 2011

Study links genetic variants in MHC region with risk of lupus in African American women

Researchers from Boston University's Slone Epidemiology Center have found four new genetic variants in the major histocompatibility complex (MHC) that confer a higher risk of systemic lupus erythemathosus in African American women.

27 Jun 2011

Idera presents IMO-3100 data on preclinical model of arthritis at FOCIS 2011

Idera Pharmaceuticals, Inc. announced today the presentation of IMO-3100 mechanism of action data in a preclinical model of arthritis.

24 Jun 2011

Positive results from etanercept pilot study against dermatomyositis

A multicenter pilot study of etanercept for treatment of dermatomyositis found no major safety concerns and many patients treated with the drug were successfully weaned from steroid therapy.

17 Jun 2011

Topline results from 4SC vidofludimus Phase IIb trial against rheumatoid arthritis

4SC AG, a discovery and development company of targeted small molecule drugs for autoimmune diseases and cancer, today announced topline results from its randomised, double-blind, placebo-controlled Phase IIb clinical trial COMPONENT in RA.

8 Jun 2011

SQI Diagnostics reports net loss of $1,874,000 for second quarter 2011

SQI Diagnostics Inc., a life sciences company that develops and commercializes proprietary multiplexing technologies and products for advanced microarray diagnostics, today announced its financial and operational results for the second quarter ended March 31, 2011.

30 May 2011

New positive Cimzia phase IIIb study data on rheumatoid arthritis presented at EULAR meeting

UCB today announced data which showed that the addition of Cimzia to current therapy was associated with a rapid and consistent clinical response in a diverse group of rheumatoid arthritis (RA) patients.

30 May 2011

4SC to present pre-clinical data on vidofludimus in systemic lupus erythematosus at EULAR 2011

4SC AG, a discovery and development company of targeted small molecule drugs for autoimmune and cancer diseases, will present pre-clinical data on vidofludimus - its lead small-molecule drug candidate against autoimmune diseases - in systemic lupus erythematosus at EULAR 2011, Europe's largest scientific conference on rheumatic diseases, in London, UK, from May 25-28, 2011.

27 May 2011

Lupus News and Research

Latest Lupus News and Research

Rigel reports net loss of $21.5 million for second quarter 2011

Anthera reports increase in second quarter total operating expenses to $22.7 million

AARDA develops a plan to calculate one's own Autoimmune Quotient

RegeneRx to initiate enrollment in RGN-259 Phase 2 trial for dry eye syndrome

Janssen receives FDA Complete Response letter for SIMPONI sBLA to treat RA

GIDAC recommends FDA approval of Janssen's REMICADE for treatment of pediatric UC

U.S. News & World Report ranks HSS as No.1 orthopedic hospital

Scientists identify key immune system regulator in white blood cells

EC grants marketing authorization for BENLYSTA to treat SLE

Study reports high prevalence of vitamin D insufficiency in patients with psoriatic arthritis

Transplants with half-matched bone marrow or cord blood are comparable to fully matched tissue

Half-matched transplants widen donor pool for leukemia and lymphoma

Zalicus commences Synavive SYNERGY Phase 2b clinical trial for rheumatoid arthritis

Study links genetic variants in MHC region with risk of lupus in African American women

Idera presents IMO-3100 data on preclinical model of arthritis at FOCIS 2011

Positive results from etanercept pilot study against dermatomyositis

Topline results from 4SC vidofludimus Phase IIb trial against rheumatoid arthritis

SQI Diagnostics reports net loss of $1,874,000 for second quarter 2011

New positive Cimzia phase IIIb study data on rheumatoid arthritis presented at EULAR meeting

4SC to present pre-clinical data on vidofludimus in systemic lupus erythematosus at EULAR 2011

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Lupus News and Research

Latest Lupus News and Research

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Newsletters you may be interested in